Literature DB >> 31702003

Prescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes: a survey of cardiologists' attitudes and practice.

Thomas A Slater1, Michael Drozd1, Victoria Palin1, Charlotte Bowles1, Mohammed A Waduud1, Rani Khatib1,2,3, Ramzi A Ajjan1,4, Stephen B Wheatcroft1,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31702003      PMCID: PMC7225869          DOI: 10.1093/ehjcvp/pvz058

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  10 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.

Authors:  Francesco Cosentino; Antonio Ceriello; Florian M M Baeres; Paola Fioretto; Alan Garber; Wendy Gattis Stough; Jyothis T George; Peter J Grant; Kamlesh Khunti; Anna Maria Langkilde; Jorge Plutzky; Lars Rydén; André Scheen; Eberhard Standl; Jaakko Tuomilehto; Faiez Zannad
Journal:  Eur Heart J       Date:  2019-09-07       Impact factor: 29.983

3.  International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study.

Authors:  Romain André; Vanina Bongard; Roberto Elosua; Inge Kirchberger; Dimitrios Farmakis; Unto Häkkinen; Danilo Fusco; Marina Torre; Pascal Garel; Carla Araújo; Christa Meisinger; John Lekakis; Antti Malmivaara; Maria Dovali; Marta Pereira; Jaume Marrugat; Jean Ferrières
Journal:  Heart       Date:  2014-05-01       Impact factor: 5.994

4.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

Review 5.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Authors:  Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 29.983

6.  2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; William T Cefalu; James L Januzzi; Rita Rastogi Kalyani; Mikhail Kosiborod; Melissa L Magwire; Pamela B Morris; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2018-11-26       Impact factor: 24.094

7.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

8.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

  10 in total
  3 in total

Review 1.  Quality of Diabetes Care in the USA.

Authors:  Ben Alencherry; Dennis Bruemmer
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

2.  Strategic Recommendations to Bridge the Gaps in Awareness, Diagnosis and Prevention of Heart Failure in the Middle East Region and Africa.

Authors:  Ahmed Bennis; Elijah N Ogola; Eric Klug; Hadi N Skouri; Hilal Bahjet Al Saffar; Hany Ragy; Kamal Waheeb AlGhalayini; Khaldoon A Alhumood; Magdy Abdelhamid; Mehmet Birhan Yilmaz; Ramzi Tabbalat; Yüksel Çavuşoğlu
Journal:  J Saudi Heart Assoc       Date:  2022-04-15

3.  National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.

Authors:  Rishav Adhikari; Kunal Jha; Zeina Dardari; James Heyward; Roger S Blumenthal; Robert H Eckel; G Caleb Alexander; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.